Zhenglin Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhenglin Zhu has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
- Geng Meng
College of Veterinary Medicine, China Agricultural University, Beijing, China
13 shared publications Kaiwen Meng
College of Veterinary Medicine, China Agricultural University
9 shared publicationsGexin Liu
School of Life Sciences, Chongqing University, No. 55 Daxuecheng South Road, Shapingba, Chongqing 401331, China
7 shared publicationsBeibei Fu
Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, China
5 shared publications- Pan Dong
School of Life Sciences, Chongqing University, Chongqing, China
5 shared publications Xiaoyuan Lin
Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, China
5 shared publications
Latest Publications
- 3 June 2026
- Published by Taylor & Francis in Future Virology
- Vol. 21 (6) , 413-422
How mutation-driven predisposition shapes the accelerated adaptive trajectory of SARS-CoV-2: the role of NSP4 T492I
- 3 June 2026
- Published by Taylor & Francis in Future Virology
- Vol. 21 (6) , 413-422
How mutation-driven predisposition shapes the accelerated adaptive trajectory of SARS-CoV-2: the role of NSP4 T492I
- Open Access
- 1 January 2026
- Published by Maximum Academic Press in Medicinal Plant Biology
- Vol. 5 (1)
Medicinal plants for radiation enteritis: key bioactive compounds and relevant antioxidant mechanisms
Radiation enteritis, a complication following cancer radiotherapy, is caused by reactive oxygen species (ROS)-mediated oxidative damage, coupled with inflammatory dysregulation and disruption of the gut microbiota. Recent advancements in phytotherapy have highlighted the potential application of plant-derived bioactive compounds (e.g., curcumin from Curcuma longa, epigallocatechin gallate [EGCG], and resveratrol) as mitigators in treating radiation-induced intestinal injury. These compounds, characterized by potent ROS-scavenging activity, excellent biocompatibility, and minimal toxicity, exhibit promising attributes for therapeutic intervention. To better understand the botanical diversity and underlying mechanisms of radiation enteritis, this review systematically profiles the alkaloid-, flavonoid-, and polyphenol-rich medicinal plants, relevant bioactive constituents, and their associated therapeutic effects in synergistic modulation of oxidative, inflammatory, and apoptotic cascades. These natural compounds effectively leverage dual antioxidant mechanisms, including direct ROS scavenging via phenolic hydroxyl groups, indirect activation of the nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1), upregulation of endogenous antioxidants, suppression of pro-inflammatory cytokines, and enhancement of tight junction proteins for barrier repair. Despite their potential as adjuvant therapies, challenges remain in identifying exact antioxidant targets and translating these into clinical applications. To address this issue, we propose a framework that integrates phytochemistry, multi-omics profiling, and AI-enabled prediction of antioxidant targets. This review aims to facilitate the development of plant-based radioprotectants as next-generation adjuvant therapies.
- 1 January 2026
- Published by Maximum Academic Press in Medicinal Plant Biology
- Vol. 5 (1)
Open AccessMedicinal plants for radiation enteritis: key bioactive compounds and relevant antioxidant mechanisms
Radiation enteritis, a complication following cancer radiotherapy, is caused by reactive oxygen species (ROS)-mediated oxidative damage, coupled with inflammatory dysregulation and disruption of the gut microbiota. Recent advancements in phytotherapy have highlighted the potential application of plant-derived bioactive compounds (e.g., curcumin from Curcuma longa, epigallocatechin gallate [EGCG], and resveratrol) as mitigators in treating radiation-induced intestinal injury. These compounds, characterized by potent ROS-scavenging activity, excellent biocompatibility, and minimal toxicity, exhibit promising attributes for therapeutic intervention. To better understand the botanical diversity and underlying mechanisms of radiation enteritis, this review systematically profiles the alkaloid-, flavonoid-, and polyphenol-rich medicinal plants, relevant bioactive constituents, and their associated therapeutic effects in synergistic modulation of oxidative, inflammatory, and apoptotic cascades. These natural compounds effectively leverage dual antioxidant mechanisms, including direct ROS scavenging via phenolic hydroxyl groups, indirect activation of the nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1), upregulation of endogenous antioxidants, suppression of pro-inflammatory cytokines, and enhancement of tight junction proteins for barrier repair. Despite their potential as adjuvant therapies, challenges remain in identifying exact antioxidant targets and translating these into clinical applications. To address this issue, we propose a framework that integrates phytochemistry, multi-omics profiling, and AI-enabled prediction of antioxidant targets. This review aims to facilitate the development of plant-based radioprotectants as next-generation adjuvant therapies.
- Open Access
- 29 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6951
A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron
How SARS-CoV-2 Omicron evolved remains obscure. T492I, an Omicron-specific mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, inferring potentials to drive evolution. Through evolve-and-resequence experiments of SARS-CoV-2 wild-type (hCoV-19/USA/WA-CDC-02982585-001/2020, A) and Delta strains (B.1.617) with or without T492I, this study demonstrates that the NSP4 mutation T492I confers accelerated phenotypic adaption and a predisposition to the emergence of SARS-CoV-2 Omicron-like variants. The T492I-driven evolution results in accelerated enhancement in viral replication, infectivity, immune evasion capacity, receptor-binding affinity and potential for cross-species transmission. Aside from elevated mutation rates and impact on deaminases, positive epistasis between T492I and adaptive mutations could potentially mechanistically facilitate the shifts in mutation spectra and indirectly determines the Omicron-predisposing evolution. These suggest a potentially important role of the driver mutation T492I in the evolution of SARS-CoV-2 Omicron variants. Our findings highlight the existence and importance of mutation-driven predisposition in viral evolution.
- 29 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 6951
Open AccessA single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron
How SARS-CoV-2 Omicron evolved remains obscure. T492I, an Omicron-specific mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, inferring potentials to drive evolution. Through evolve-and-resequence experiments of SARS-CoV-2 wild-type (hCoV-19/USA/WA-CDC-02982585-001/2020, A) and Delta strains (B.1.617) with or without T492I, this study demonstrates that the NSP4 mutation T492I confers accelerated phenotypic adaption and a predisposition to the emergence of SARS-CoV-2 Omicron-like variants. The T492I-driven evolution results in accelerated enhancement in viral replication, infectivity, immune evasion capacity, receptor-binding affinity and potential for cross-species transmission. Aside from elevated mutation rates and impact on deaminases, positive epistasis between T492I and adaptive mutations could potentially mechanistically facilitate the shifts in mutation spectra and indirectly determines the Omicron-predisposing evolution. These suggest a potentially important role of the driver mutation T492I in the evolution of SARS-CoV-2 Omicron variants. Our findings highlight the existence and importance of mutation-driven predisposition in viral evolution.
- 6 May 2025
- Published by Springer Nature in Journal of Soil Science and Plant Nutrition
- Vol. 25 (2) , 4491-4502
Quality Analysis of Different Kiwifruit Cultivars and Their Relationship with Soil Elements
- 6 May 2025
- Published by Springer Nature in Journal of Soil Science and Plant Nutrition
- Vol. 25 (2) , 4491-4502
Quality Analysis of Different Kiwifruit Cultivars and Their Relationship with Soil Elements
- Open Access
- 15 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13442
The Induction of Disease Resistance by Scopolamine and the Application of Datura Extract Against Potato (Solanum tuberosum L.) Late Blight
Late blight, caused by Phytophthora infestans, is a devastating disease of potato. Our previous work illustrated that scopolamine, the main bioactive substance of Datura extract, exerts direct inhibitory effects on P. infestans, but it is unclear whether scopolamine and Datura extract can boost resistance to late blight in potato. In this study, P. infestans is used to infect scopolamine-treated potato pieces and leaves, as well as whole potatoes. We found that scopolamine-treated potato is resistant to P. infestans both in vitro and in vivo. The treatment of 4.5 g/L scopolamine reduces the lesion size of whole potato to 54% compared with the control after 20 d of the infection of P. infestans. The disease-resistant substance detection based on the kit method shows that scopolamine triggers the upregulation of polyphenoloxidase, peroxidase, superoxide dismutase activities, and H2O2 contents in potato tubers, and the decline of phenylalanine ammonia lyase and catalase activity. A total of 1682 significantly differentially expressed genes were detected with or without scopolamine treatment through high-throughput transcriptome sequencing and the DESeq2 software (version 1.24.0), including 705 upregulated and 977 downregulated genes. Scopolamine may affect the genes functioning in the cell wall, membrane and the plant-pathogen interaction. The addition of Datura extract could directly inhibit the mycelial growth of P. infestans on rye plate medium. In addition, P. infestans was found to be resistant to late blight in potato pieces treated with Datura extract. Datura extract can also be utilized in combination with the chemical fungicide Infinito in field experiments to lessen late blight symptoms and enhance potato yield. To our knowledge, this is the first study to detect the induction of disease resistance by scopolamine, and it also explores the feasibility of Datura extract in potato disease resistance.
- 15 December 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (24) , 13442
Open AccessThe Induction of Disease Resistance by Scopolamine and the Application of Datura Extract Against Potato (Solanum tuberosum L.) Late Blight
Late blight, caused by Phytophthora infestans, is a devastating disease of potato. Our previous work illustrated that scopolamine, the main bioactive substance of Datura extract, exerts direct inhibitory effects on P. infestans, but it is unclear whether scopolamine and Datura extract can boost resistance to late blight in potato. In this study, P. infestans is used to infect scopolamine-treated potato pieces and leaves, as well as whole potatoes. We found that scopolamine-treated potato is resistant to P. infestans both in vitro and in vivo. The treatment of 4.5 g/L scopolamine reduces the lesion size of whole potato to 54% compared with the control after 20 d of the infection of P. infestans. The disease-resistant substance detection based on the kit method shows that scopolamine triggers the upregulation of polyphenoloxidase, peroxidase, superoxide dismutase activities, and H2O2 contents in potato tubers, and the decline of phenylalanine ammonia lyase and catalase activity. A total of 1682 significantly differentially expressed genes were detected with or without scopolamine treatment through high-throughput transcriptome sequencing and the DESeq2 software (version 1.24.0), including 705 upregulated and 977 downregulated genes. Scopolamine may affect the genes functioning in the cell wall, membrane and the plant-pathogen interaction. The addition of Datura extract could directly inhibit the mycelial growth of P. infestans on rye plate medium. In addition, P. infestans was found to be resistant to late blight in potato pieces treated with Datura extract. Datura extract can also be utilized in combination with the chemical fungicide Infinito in field experiments to lessen late blight symptoms and enhance potato yield. To our knowledge, this is the first study to detect the induction of disease resistance by scopolamine, and it also explores the feasibility of Datura extract in potato disease resistance.
- Open Access
- 1 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (21) , 11757
Identifying the HIV-Resistance-Related Factors and Regulatory Network via Multi-Omics Analyses
For research on HIV/AIDS, it is important to elucidate the complex viral–host interaction, host dependency factors (HDFs), and restriction factors. However, the regulatory network of HIV-resistance-related factors remains not well understood. Therefore, we integrated four publicly available HIV-related transcriptome datasets, along with three datasets on HIV-infection-related DNA methylation, miRNA, and ChIP-seq, to predict the factors influencing HIV resistance and infection. Our approach involved differential analysis, functional annotation, and protein–protein interaction network analysis. Through comprehensive analyses, we identified 25 potential HIV-resistance-related genes (including shared EGF) and 24 HIV-infection-related hub genes (including shared JUN). Additionally, we pinpointed five key differentially methylated genes, five crucial differentially expressed microRNAs, and five significant pathways associated with HIV resistance. We mapped the potential regulatory pathways involving these HIV-resistance-related factors. Among the predicted factors, RHOA, RAD51, GATA1, IRF4, and CXCL8 have been validated as HDFs or restriction factors. The identified factors, such as JUN, EGF, and PLEK, are potential HDFs or restriction factors. This study uncovers the gene signatures and regulatory networks associated with HIV-1 resistance, suggesting potential targets for the development of new therapies against HIV/AIDS.
- 1 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (21) , 11757
Open AccessIdentifying the HIV-Resistance-Related Factors and Regulatory Network via Multi-Omics Analyses
For research on HIV/AIDS, it is important to elucidate the complex viral–host interaction, host dependency factors (HDFs), and restriction factors. However, the regulatory network of HIV-resistance-related factors remains not well understood. Therefore, we integrated four publicly available HIV-related transcriptome datasets, along with three datasets on HIV-infection-related DNA methylation, miRNA, and ChIP-seq, to predict the factors influencing HIV resistance and infection. Our approach involved differential analysis, functional annotation, and protein–protein interaction network analysis. Through comprehensive analyses, we identified 25 potential HIV-resistance-related genes (including shared EGF) and 24 HIV-infection-related hub genes (including shared JUN). Additionally, we pinpointed five key differentially methylated genes, five crucial differentially expressed microRNAs, and five significant pathways associated with HIV resistance. We mapped the potential regulatory pathways involving these HIV-resistance-related factors. Among the predicted factors, RHOA, RAD51, GATA1, IRF4, and CXCL8 have been validated as HDFs or restriction factors. The identified factors, such as JUN, EGF, and PLEK, are potential HDFs or restriction factors. This study uncovers the gene signatures and regulatory networks associated with HIV-1 resistance, suggesting potential targets for the development of new therapies against HIV/AIDS.
- Open Access
- 1 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9520
Phenotypic, Metabolic and Genetic Adaptations of the Ficus Species to Abiotic Stress Response: A Comprehensive Review
The Ficus genus, having radiated from the tropics and subtropics to the temperate zone worldwide, is the largest genus among woody plants, comprising over 800 species. Evolution of the Ficus species results in genetic diversity, global radiation and geographical differentiations, suggesting adaption to diverse environments and coping with stresses. Apart from familiar physiological changes, such as stomatal closure and alteration in plant hormone levels, the Ficus species exhibit a unique mechanism in response to abiotic stress, such as regulation of leaf temperature and retention of drought memory. The stress-resistance genes harbored by Ficus result in effective responses to abiotic stress. Understanding the stress-resistance mechanisms in Ficus provides insights into the genetic breeding toward stress-tolerant crop cultivars. Following upon these issues, we comprehensively reviewed recent progress concerning the Ficus genes and relevant mechanisms that play important roles in the abiotic stress responses. These highlight prospectively important application potentials of the stress-resistance genes in Ficus.
- 1 September 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (17) , 9520
Open AccessPhenotypic, Metabolic and Genetic Adaptations of the Ficus Species to Abiotic Stress Response: A Comprehensive Review
The Ficus genus, having radiated from the tropics and subtropics to the temperate zone worldwide, is the largest genus among woody plants, comprising over 800 species. Evolution of the Ficus species results in genetic diversity, global radiation and geographical differentiations, suggesting adaption to diverse environments and coping with stresses. Apart from familiar physiological changes, such as stomatal closure and alteration in plant hormone levels, the Ficus species exhibit a unique mechanism in response to abiotic stress, such as regulation of leaf temperature and retention of drought memory. The stress-resistance genes harbored by Ficus result in effective responses to abiotic stress. Understanding the stress-resistance mechanisms in Ficus provides insights into the genetic breeding toward stress-tolerant crop cultivars. Following upon these issues, we comprehensively reviewed recent progress concerning the Ficus genes and relevant mechanisms that play important roles in the abiotic stress responses. These highlight prospectively important application potentials of the stress-resistance genes in Ficus.
- Open Access
NSP4 mutation T492I drives rapid evolution of SARS-CoV-2 toward Omicron
T492I, a mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, causing potential evolutionary impacts. Through comprehensive comparative analyses based on evolve-and-resequence experiments of SARS-CoV-2 wild-type and Delta strains with or without T492I, we demonstrate that NSP4 T492I not only increases the mutation rate, but also accelerates the emergence of many mutations characteristic for Omicron variants. Accordingly, viral populations that evolved from ancestors with T492I, show Omicron-biased selective forces and increases in viral replication, infectivity, immune evasion capacity, potentials for cross-species transmission and receptor-binding affinity. Aside from enhanced replication, we observed stronger epistasis regarding viral replication and infectivity in T492I than in S N501Y and NSP6 ∆SGF; this facilitates the regulation of mutation types, which can drive fast evolution of Omicron specific mutations. Our results highlight the role of an important replication-enhancing mutation in regulating the evolutionary rates and mutational trends of SARS-CoV-2.
Open AccessNSP4 mutation T492I drives rapid evolution of SARS-CoV-2 toward Omicron
T492I, a mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, causing potential evolutionary impacts. Through comprehensive comparative analyses based on evolve-and-resequence experiments of SARS-CoV-2 wild-type and Delta strains with or without T492I, we demonstrate that NSP4 T492I not only increases the mutation rate, but also accelerates the emergence of many mutations characteristic for Omicron variants. Accordingly, viral populations that evolved from ancestors with T492I, show Omicron-biased selective forces and increases in viral replication, infectivity, immune evasion capacity, potentials for cross-species transmission and receptor-binding affinity. Aside from enhanced replication, we observed stronger epistasis regarding viral replication and infectivity in T492I than in S N501Y and NSP6 ∆SGF; this facilitates the regulation of mutation types, which can drive fast evolution of Omicron specific mutations. Our results highlight the role of an important replication-enhancing mutation in regulating the evolutionary rates and mutational trends of SARS-CoV-2.
- 21 December 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 258 (Pt 1) , 128880
A comprehensive review of TGA transcription factors in plant growth, stress responses, and beyond
- 21 December 2023
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 258 (Pt 1) , 128880
A comprehensive review of TGA transcription factors in plant growth, stress responses, and beyond
- 3 July 2023
- Published by Elsevier in Cell Host & Microbe
- Vol. 31 (7) , 1170-1184.e7
The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage
- 3 July 2023
- Published by Elsevier in Cell Host & Microbe
- Vol. 31 (7) , 1170-1184.e7
The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage